Fingerprint
Dive into the research topics of 'CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically